Patients receiving hemodialysis (HD) are at risk of TB development. IGRA-positive patients showed significant decrease in quantitative IGRA result with alterations in CD3+CD4+CD45RO+, NK cell, and monocyte subsets immediately upon HD procedure. Our result suggested that the timing of IGRA testing is crucial in end-stage renal disease population.

Original languageEnglish
Pages (from-to)332-335
Number of pages4
JournalJournal of Microbiology, Immunology and Infection
Issue number2
Publication statusPublished - Apr 2022


  • End stage renal disease
  • Hemodialysis
  • IGRA variability
  • Interferon gamma-release assay
  • Peripheral immune profile

ASJC Scopus subject areas

  • Immunology and Allergy
  • General Immunology and Microbiology
  • Microbiology (medical)
  • Infectious Diseases


Dive into the research topics of 'Hemodialysis acutely altered interferon-gamma release assay test result and immune cell profile'. Together they form a unique fingerprint.

Cite this